Package Leaflet: Information for the User
Clopidogrel ratiopharm 75 mg film-coated tablets EFG
clopidogrel
Read the entire package leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the package leaflet
Clopidogrel ratiopharm contains clopidogrel and belongs to a group of medicines called antiplatelet agents. Platelets are very small cells in the blood that clump together to form blood clots. Antiplatelet agents prevent this clumping, reducing the risk of blood clots (a process called thrombosis).
Clopidogrel ratiopharm is given to adults to prevent blood clots (thrombi) in blood vessels (arteries) that have become hardened (a process known as atherothrombosis), which can lead to atherothrombotic events (such as stroke, myocardial infarction, or death).
You have been prescribed Clopidogrel ratiopharm to help prevent blood clots and reduce the risk of these serious events because:
Do not take Clopidogrel ratiopharm
If you think any of these apply to you, or if you are in any doubt, consult your doctor before taking Clopidogrel ratiopharm.
Warnings and precautions
Consult your doctor or pharmacist before starting Clopidogrel ratiopharm
While you are taking Clopidogrel ratiopharm:
Children and adolescents
This medicine should not be given to children because it is not effective.
Other medicines and Clopidogrel ratiopharm
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Some of these medicines may affect the use of Clopidogrel ratiopharm or vice versa.
You must specifically tell your doctor if you are taking:
If you have had severe chest pain (unstable angina or myocardial infarction), a transient ischemic attack, or a mild ischemic stroke, you may have been prescribed Clopidogrel ratiopharm in combination with acetylsalicylic acid, a substance found in many medications used to relieve pain and lower fever. A dose of acetylsalicylic acid given occasionally (not exceeding 1,000 mg in 24 hours) should not normally cause any problems, but prolonged use in other circumstances should be discussed with your doctor.
Taking Clopidogrel ratiopharm with food and drinks
Clopidogrel ratiopharm can be taken with or without food.
Pregnancy and breastfeeding
It is preferable not to take this medicine during pregnancy.
If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. If you become pregnant while taking Clopidogrel ratiopharm, inform your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.
You should not breastfeed while taking this medicine.
If you are breastfeeding or plan to breastfeed, consult your doctor before taking this medicine.
Consult your doctor or pharmacist before taking any medicine.
Driving and using machines
Clopidogrel ratiopharm is unlikely to affect your ability to drive or use machines.
Clopidogrel ratiopharm contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Clopidogrel ratiopharm contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially, "sodium-free".
Follow the instructions for administration of this medicine exactly as prescribed by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
The recommended dose, even for patients with a disease called "atrial fibrillation" (an irregular heartbeat), is one 75 mg tablet of Clopidogrel ratiopharm per day, taken orally with or without food and at the same time each day.
If you have had severe chest pain (unstable angina or myocardial infarction), your doctor may prescribe you 300 mg or 600 mg of clopidogrel (1 or 2 tablets of 300 mg or 4 or 8 tablets of 75 mg) to be taken once at the start of treatment. After that, the recommended dose is one 75 mg tablet of Clopidogrel ratiopharm per day as described above.
If you have experienced symptoms of a stroke that disappear within a short period (also known as a transient ischemic attack) or a mild ischemic stroke, your doctor may prescribe you 300 mg of Clopidogrel ratiopharm (4 tablets of 75 mg) once at the start of treatment. After that, the recommended dose is one 75 mg tablet of Clopidogrel ratiopharm per day as described above, with acetylsalicylic acid for 3 weeks. After that, your doctor will prescribe either Clopidogrel ratiopharm alone or acetylsalicylic acid alone.
You should take Clopidogrel ratiopharm for as long as your doctor continues to prescribe it.
Please note that the instructions for removing the tablet from the blister pack with a peelable lid are on the outside of the box of blister packs with a peelable lid.
If you take more Clopidogrel ratiopharm than you should
Contact your doctor or go to the emergency department of the nearest hospital, as there is a greater risk of bleeding.
If you forget to take Clopidogrel ratiopharm
If you forget to take a dose of Clopidogrel ratiopharm, but remember before 12 hours have passed since the time you should have taken the medication, take the tablet immediately and the next one at the usual time.
If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet.
In the 28x1 tablet format, you can check the last day you took a Clopidogrel ratiopharm tablet by looking at the calendar printed on the blister pack.
If you stop taking Clopidogrel ratiopharm
Do not stop your treatment unless your doctor tells you to. Contact your doctor or pharmacist before stopping this medicine.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor immediately if you experience:
The most common side effect reported with Clopidogrel ratiopharm is bleeding.
Bleeding can occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in the urine. In a small number of cases, bleeding in the eye, inside the head, abdomen, lungs, and joints.
If you experience prolonged bleeding while taking Clopidogrel ratiopharm
If you cut or injure yourself, it is possible that the bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medicine, as it prevents the blood's ability to form clots. For minor cuts or injuries (such as when shaving), this is usually not important. However, if you have any doubts, the bleeding worsens, or you experience unexpected bleeding in unusual places in your body, you should contact your doctor immediately (see section 2 "Warnings and precautions").
Other side effects include:
Common side effects (may affect up to 1 in 10 people):
Diarrhea, abdominal pain, indigestion, or stomach upset
Uncommon side effects (may affect up to 1 in 100 people)
Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, feeling of tingling and numbness.
Rare side effects (may affect up to 1 in 1,000 people):
Dizziness, breast enlargement in men.
Very rare side effects (may affect up to 1 in 10,000 people):
Jaundice; severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g., feeling of heat with sudden general discomfort leading to fainting); swelling of the mouth; blisters on the skin, skin allergy; inflammation of the mucous membrane of the mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.
Side effects of unknown frequency (cannot be estimated from the available data): Hypersensitivity reactions with chest or abdominal pain, persistent symptoms of low blood sugar.
Additionally, your doctor may observe changes in the results of your blood or urine tests.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, bottle, or blister after EXP. The expiry date is the last day of the month shown.
No special storage conditions are required.
Do not use this medicine if you notice any visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Clopidogrel ratiopharm Composition
Product Appearance and Package Contents
Formats containing 14x1, 28x1, 30x1, 50x1, 84x1, 90x1, or 100x1 tablets;
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Teva B.V.
Swensweg 5,
2031GA Haarlem,
Netherlands
Manufacturer:
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13,
4042 Debrecen,
Hungary
Merckle GmbH
Ludwig-Merckle-Straße 3
89143 Blaubeuren
Germany
Balkanpharma Dupnitsa AD
3 Samokovsko Shosse Str.,
Dupnitsa 2600,
Bulgaria
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
België/Belgique/Belgien Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373 | Lietuva UAB Teva Baltics Tel: +370 52660203 |
Luxembourg/Luxemburg ratiopharm GmbH Allemagne/Deutschland Tél/Tel: +49 73140202 | |
Ceská republika Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007111 | Magyarország Teva Gyógyszergyár Zrt. Tel: +36 12886400 |
Danmark Teva Denmark A/S Tlf: +45 44985511 | Malta Teva Pharmaceuticals Ireland L-Irlanda Tel: +44 2075407117 |
Deutschland ratiopharm GmbH Tel: +49 73140202 | Nederland Teva Nederland B.V. Tel: +31 8000228400 |
Eesti UAB Teva Baltics Eesti filiaal Tel: +372 6610801 | Norge Teva Norway AS Tlf: +47 66775590 |
Ελλάδα Specifar Α.Β.Ε.Ε. Τηλ: +30 2118805000 | Österreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070 |
España Teva Pharma, S.L.U. Tel: +34 913873280 | Polska Teva Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459300 |
France Teva Santé Tél: +33 155917800 | Portugal Teva Pharma - Produtos Farmacêuticos, Lda. Tel: +351 214767550 |
Hrvatska Pliva Hrvatska d.o.o. Tel: +385 13720000 | România Teva Pharmaceuticals S.R.L. Tel: +40 212306524 |
Ireland Teva Pharmaceuticals Ireland Tel: +44 2075407117 | Slovenija Pliva Ljubljana d.o.o. Tel: +386 15890390 |
Ísland Teva Pharma Iceland ehf. Sími: +354 5503300 | Slovenská republika TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267911 |
Italia Teva Italia S.r.l. Tel: +39 028917981 | Suomi/Finland Teva Finland Oy Puh/Tel: +358 201805900 |
Κύπρος Specifar Α.Β.Ε.Ε. Ελλάδα Τηλ: +30 2118805000 | Sverige Teva Sweden AB Tel: +46 42121100 |
Latvija UAB Teva Baltics filiale Latvija Tel: +371 67323666 | United Kingdom (Northern Ireland) Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407117 |
Date of the last revision of this leaflet: {MM/AAAA}.
Detailed information on this medicinal product is available on the European Medicines Agency website http://www.ema.europa.eu.